Presentation The GARD®skin Medical Device assay for assessing the skin sensitizing potential of medical devices: A case study on the use of in vitro data in the biological evaluation for CE marking according to MDR Key Points A proof-of-concept study using the GARD®skin Medical Device assay to evaluate the skin sensitizing potential of medical device […]
Join our upcoming free webinar to explore the effective utilization of in vitro methods for safety assessment of materials during product development of Medical Devices. We will discuss recent advancements in in vitro methods for assessing the endpoints of skin irritation and skin sensitization. Learn how to integrate these assessments into your product development process […]
Join our upcoming webinar to explore the recent advancement in GARD® for Skin Sensitization assessment, with a specific focus on substances that fall outside the applicability domains of the conventional in vitro assays in the OECD Test Guidelines. Our skin sensitization experts will address challenges posed by various Difficult-to-Test substances, discussing the applicability domain of […]
Booth #732 Discuss your testing needs with us Exhibitor-Hosted Session Expert round table on NAMs and industry trends Tuesday, 12 Mar | 9:00 am-10:00 am Posters Spotlight on PoD, NESILs, product development and CE-marking of Medical Devices Monday, 11 Mar | 9:15 am-11:15 am 🎫 Joint poster with Sonova P487 #3362 | Unveiling skin sensitizing potential: case studies […]
Spotlight on Applicability Domain, Quantitative Potency Assessment and Medical Devices In case you missed SenzaGen’s poster presentations and scientific session at this year’s SOT, we are pleased to offer you a new opportunity to participate on April 23, 2024! In this webinar Dr Andy Forreryd, SenzaGen's in vitro toxicology expert, will summarize the latest GARD data from industry collaborations: […]
Program 'Introduction to GARDskin (OECD TG 442E) for evaluation of skin sensitization hazard with dose-response option for quantitative risk assessment' Date: 30/05 Session 1: Safety: from irritation to sensitization Presenter: Andy Forreryd, SenzaGen Booth: #21
Come meet us at booth #22 and join our presentations to hear the latest news about GARD® and how the assays are used to fill data gaps for skin sensitizing hazard and quantitative potency assessment. Additionally, meet ToxHub, a SenzaGen Group company, and benefit from expert toxicology and regulatory advice. Presentations and Posters Our team […]
Meet us in Liverpool at the the 11th meeting of Immunotoxicology & Chemical Allergy (ITCASS) and the 30th meeting of European Research Group on Experimental Contact Dermatitis (ERGECD).
Spotlight on in vitro quantitative assessment of skin sensitizing potency. Join our upcoming webinar to explore the recent advancement in GARD® for quantitative assessment of skin sensitizing potency. This session will present a meta-analysis of GARD® data covering over 200 chemicals, including three blinded datasets generated in collaboration with industry partners. These data will demonstrate […]
Meet us at Booth #56 Come meet us at booth #56 and join our presentations to hear the latest news about GARD® and how the assays are used to fill data gaps in skin sensitizing hazard and quantitative potency assessment. Additionally, meet ToxHub, a SenzaGen Group company, and benefit from expert toxicology and regulatory advice. […]
